0001214659-24-005472.txt : 20240328
0001214659-24-005472.hdr.sgml : 20240328
20240328163050
ACCESSION NUMBER: 0001214659-24-005472
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240326
FILED AS OF DATE: 20240328
DATE AS OF CHANGE: 20240328
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: AULT MILTON C III
CENTRAL INDEX KEY: 0001212502
ORGANIZATION NAME:
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40483
FILM NUMBER: 24799594
MAIL ADDRESS:
STREET 1: 11411 SOUTHERN HIGHLANDS PARKWAY
STREET 2: SUITE 240
CITY: LAS VEGAS
STATE: NV
ZIP: 89141
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Alzamend Neuro, Inc.
CENTRAL INDEX KEY: 0001677077
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 811822909
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0430
BUSINESS ADDRESS:
STREET 1: 3500 LENOX RD. NE
STREET 2: SUITE 1500
CITY: ATLANTA
STATE: GA
ZIP: 30326
BUSINESS PHONE: 844-722-6333
MAIL ADDRESS:
STREET 1: 3500 LENOX RD. NE
STREET 2: SUITE 1500
CITY: ATLANTA
STATE: GA
ZIP: 30326
4
1
marketforms-65403.xml
PRIMARY DOCUMENT
X0508
4
2024-03-26
0001677077
Alzamend Neuro, Inc.
ALZN
0001212502
AULT MILTON C III
11411 SOUTHERN HIGHLANDS PARKWAY
SUITE 240
LAS VEGAS
NV
89141
true
false
true
false
0
Series B Convertible Preferred Stock
1.00
2024-03-26
4
P
false
780
1000.00
A
2024-03-26
Common Stock
780000
2000
I
By Ault Lending, LLC
Warrants
1.20
2024-03-26
4
P
false
780000
0.00
A
2024-09-26
2029-09-26
Common Stock
780000
2000000
I
By Ault Lending, LLC
The shares of series B convertible preferred stock (the "Series B Convertible Preferred Stock") have no expiration date.
Each share of Series B Convertible Preferred Stock has a stated value of $1,000 (the "Stated Value") and is convertible into a number of shares of common stock determined by dividing the Stated Value by the conversion price, which is currently $1.00.
Ault Lending, LLC ("Ault Lending"), is a wholly-owned subsidiary of Ault Alliance, Inc. ("AAI"). Mr. Ault, the Executive Chairman of AAI, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending.
The Issuer is restricted from issuing shares of common stock upon conversion of the Series B Convertible Preferred Stock and /or exercise of the warrants to the extent such issuances would result in an aggregate number of shares of common stock exceeding 1,322,951, which represents 19.99% of the total shares of common stock issued and outstanding as of January 31, 2024, the execution date of the purchase agreement pursuant to which the shares of Series B Convertible Preferred Stock and warrants are issued, in accordance with the rules and regulations of the Nasdaq Stock Market unless the Issuer first obtains stockholder approval, which has not yet been obtained.
These warrants were issued for no additional consideration in connection with the purchase of the Series B Convertible Preferred Stock.
/s/ Milton C. Ault, III
2024-03-28